Trump Administration· ProPublica

Top U.S. Health Official Backed a Medication Policy Shift That Benefited a Company She Has Stock In

By Corey G. Johnson, ProPublica · October 29, 2026

Last November, the Department of Health and Human Services announced the elimination of “black box” warnings on hormone replacement therapies, aiming to reverse nearly two decades of stigma surrounding a key treatment for menopause symptoms. Among the officials at a press conference about the decision was Alicia…

Continue readingRead the full story at ProPublica

Top U.S. Health Official Backed a Medication Policy Shift That Benefited a Company She Has Stock In

More in Trump Administration

Trump’s State Department Is Giving $1 Million to Controversial Group to Study Crimes Against White South Africans

The Secret Terms of Trump’s Venezuelan Oil Deal

“A Massive Power Grab”: White House Proposal Threatens Funding That Helps Disabled Americans Vote